June 01, 2011
With more clinical trials conducted overseas, sponsors are facing new obstacles.
May 01, 2006
CSR is in the best interest of the public at large...and the pharmaceutical company itself.
November 01, 2005
This Asian market holds great potential for the future, including possible collaborations with global pharma partners.
March 01, 2005
The Declaration of Helsinki requires that control groups receive the “best” current treatment, not the “local” one. This shift in wording has profound implications.
August 01, 2004
Long overlooked as global drug innovators, Japanese pharmaceutical companies are gaining attention for their novel clinical development programs.
February 01, 2003
To minimize time to market, sponsors must explore new subject recruitment techniques.